Denver, CO, May 02, 2017 –(PR.com)– cliexa-RA, cliexa™’s rheumatoid arthritis app, has been scored among the 19 best RA apps selected from 700+ apps to NIH research:
The review highlights which apps weigh ACR/EULAR treatment guidelines and which include DAS28, among other important features. Researchers rank the apps using the Mobile Application Rating Scale (MARS). A scientific review of mobile apps for tracking rheumatoid arthritis disease activity finds that most apps are either simple calculators for physicians to measure disease activity or tools for patients to track symptoms, most of which do not uniformly collect data using validated instruments or composite disease activity measures.
cliexa’s Co-Founder and CEO Mehmet Kazgan says “cliexa™ changes doctor and patient behavior by connecting patients, clinicians and insurers to better care for and manage chronic conditions which translates into significant cost savings, a better doctor and patient experiences and better outcomes yielding higher customer defined value.” RA Medical Director of cliexa, Dr. Spencer stated that, “In today’s demanding medical environment physicians have limited time to gather relevant data, much less calculate an activity index. With an easily used technology application, patients can be instrumental in helping their doctors determine their disease activity, which, in turn, can lead to better informed treatment decisions. With cliexa-RA we are offering a free mobile application to achieve this goal.”
cliexa staff consists of executive healthcare professionals, physicians, scientists and technologists. cliexa’s first mobile platform, cliexa-RA for Rheumatoid Arthritis has been released to Apple Store in January 2016 and since then, cliexa has developed 3 disease tracking applications, both in iOS and Android platform for Rheumatoid Arthritis (cliexa-RA), Inflammatory Bowel Diseases (cliexa-IBD) and Chronic Obstructive Pulmonary Disease (cliexa-OPD). In November 2016, cliexa has partnered with nation’s biggest payor and provider to run a clinical study with cliexa-RA and raised more than $500K. cliexa platform is a SaaS model offered to end users, clinics, payors and pharma companies for tracking chronic disease symptoms and analytics.
Rocky Mountain Gastroenterology hosted 16th Annual GI Pow Wow on Saturday, April 8th, 2017 at the Hyatt Regency DTC.
There were nearly 500 attendees for the event, which is designed to provide a Gastroenterology and Hepatology update to specialists and primary care providers from the Colorado medical community. cliexa was one of the featured companies that exhibited at the main area. Attendees of this event received CME credits, and a COPIC point for insured providers.
This year’s event was highlighted by presentations from some of the top GI specialists from throughout the country including:
Sammy Saab, MD, Professor of Medicine & Surgery and Director of Outcomes
“Essential for the Practitioner: Auto Immune Liver Disorders”
Nitika Arora Gupta, MD, Pediatric Gastroenterology & Hepatology Specialist
“Essential for the Practitioner: Approach to the Jaundiced Child”
Gary Wu, MD, Ferdinand G. Weisbrod Professor in Gastroenterology at UPenn
“Essential for the Practitioner: Good bacteria vs. Bad bacteria in the gut”
Eric Lawitz, MD, Scientific Research Development at Texas Liver Institute & Clinical Professor of Medicine at University of Texas Health Science Center
“Essential for the Practitioner: Complications of Cirrhosis and GI bleeds”
Shervin Rabizadeh, MD, Director of Pediatric Inflammatory Bowel Disease & Pediatric
“Essential for the Practitioner: Diarrhea in children: Infections vs. IBD”
Jason Samarasena, MD
Director of Advanced Endoscopic Imaging & Professor of Medicine
at H.H. Chao Comprehensive Digestive Disease Center at UCIrvine
“Essential for the Practitioner: Esophageal Cancer: Risk, Prevention, Therapy”
David Schwartz, MD
Director of Inflammatory Bowel Disease Center and Professor of Medicine at Vaderbilt University
“Essential for the Practitioner: IBD & Perianal Disease”
3513 Brighton Blvd, Suite 520
Denver, CO 80216